PHARMA

Dishman Carbogen Amcis shares in focus as company allots 3,800 NCDs

By Bharath K S •
Dishman Carbogen Amcis Ltd allotted 3,800 senior, secured, rated, listed, redeemable, transferable non-convertible debentures of face value INR 1,00,000 each, aggregating to INR 38 crore, informing...

Why did Dishman Carbogen Amcis Ltd shares fall today?

Dishman Carbogen Amcis Ltd shares were trading at ₹152.0, down by 0.62%, on Thursday at 01:24 PM. The modest decline in the stock price came after the company announced the allotment of 3,800 senior, secured, rated, listed, redeemable, taxable, transferable non-convertible debentures (NCDs) each with a face value of ₹1,00,000, aggregating to a total of ₹38 crore. The allotment was approved by the Management Committee of the Board of Directors at a meeting held on Thursday, October 15, 2026, which commenced at 12:35 PM and concluded at 01:00 PM.

The NCDs issued by Dishman Carbogen Amcis are classified as debt instruments, meaning the company is taking on additional debt to raise capital. These debentures were part of a larger plan that received board approval on October 7, 2026, following a board meeting conducted on October 2, 2026. The company disclosed this information in compliance with SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, specifically under Regulations 30 and 51, and shared the intimation with both the BSE (Scrip Code No. 540701) and the National Stock Exchange of India Ltd (Symbol: DCAL).

Investors may have reacted cautiously to the fresh debt issuance, as additional borrowing can put pressure on the company's balance sheet and affect its interest obligations going forward. Although the share price decline is relatively small at 0.62%, the market appears to have priced in some degree of uncertainty surrounding the company's growing debt load. The allotment of ₹38 crore worth of NCDs adds to the company's existing debt profile, and market participants will likely keep a close watch on how Dishman Carbogen Amcis manages its financial leverage and interest commitments in the coming quarters.

What does Dishman Carbogen Amcis Ltd do?

Dishman Carbogen Amcis Ltd is a publicly listed company on both the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE), trading under the equity symbol DCAL and carrying multiple scrip codes for both equity and debt instruments. The company is actively involved in corporate fundraising and capital market operations, as evidenced by its issuance and allotment of senior, secured, rated, listed, redeemable, taxable, and transferable non-convertible debentures to raise substantial capital for its business needs.

The company demonstrated its capacity for large-scale debt financing by approving and subsequently allotting 3,800 non-convertible debentures, each with a face value of INR 1,00,000, aggregating to a total of INR 38 crores. This allotment was carried out in compliance with SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, following a formal board meeting and proper disclosure to both stock exchanges. Dishman Carbogen Amcis Ltd maintains an active presence in India's listed corporate securities market, utilizing both equity and debt platforms to support its financial and operational objectives.

Dishman Carbogen Amcis Ltd Financials

In Crores
720
-13
Dec 2025
851
22
Mar 2026
Revenue
Net Profit

Dishman Carbogen Amcis Ltd reported a revenue of ₹719.8 Crores in December 2025, which increased to ₹851.4 Crores in March 2026, reflecting a quarter-on-quarter growth of approximately 18.3%. The company's profitability followed a positive turnaround over the same period, moving from a loss of ₹-12.97 Crores in December 2025 to a profit of ₹21.74 Crores in March 2026, indicating a substantial recovery of ₹34.71 Crores in net results. This shift from a net loss to a net profit, accompanied by rising revenue, suggests improving operational performance and financial health for the company during the quarter ending March 2026.

Dishman Carbogen Amcis Ltd Shareholding Pattern

Holdings
Promoter
59.32%
FIIs
6.86%
DIIs
2.06%
Public
31.76%

Promoter holding stands at 59.32% of the total share capital. Foreign Institutional Investors (FIIs) hold 6.86% stake in the company, while Domestic Institutional Investors (DIIs) hold 2.06%. Public shareholders hold the remaining 31.76% stake in Dishman Carbogen Amcis Ltd.

Dishman Carbogen Amcis Ltd FAQs

Q: Why did Dishman shares fall 0.62% today?

Pls. find enclosed herewith intimation of allotment of 3800 NCDs.. This corporate action caught investor attention, leading to increased trading activity in the stock.

Q: What is the shareholding pattern of Dishman Carbogen Amcis Ltd?

As per the latest data, promoters hold 59.32% stake in Dishman Carbogen Amcis Ltd, while FII holding stands at 6.86%. Domestic institutional investors hold 2.06%, and public shareholders account for 31.76% of the equity.

Q: What is the current stock price of Dishman Carbogen Amcis Ltd?

Dishman Carbogen Amcis Ltd shares are currently trading at ₹152.0, recording a decline of 0.62% from the previous close.

Q: What is the market capitalization of Dishman Carbogen Amcis Ltd?

The company currently has a market capitalization of ₹2383.1 crore, reflecting its valuation in the Indian equity market.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. The stock prices mentioned are as of the time of writing. Bharath K S and the publisher do not hold any positions in the stocks mentioned. Please consult a SEBI-registered financial advisor before making any investment decisions.